Susan Hasty, Publisher
Table of Contents . . . April 28th, 1997Non-Subscriber - Summaries Only
Conference Coverage (AACR) - Antisense Therapy Shows Promise Against Prostate Cancer
Conference Coverage (AACR) - Pathological Implications of HIV-1 Tat in HIV-1 Related Malignancies
Conference Coverage (AACR) - Suicide Gene Therapy Approach Uses E. Coli PNP
Conference Coverage (AACR) - Suicide Gene Therapy Options Expand
Conference Coverage (AACR) - Tissue Specific Promoters Target Gene Therapy to Lung Cancer
AIDS Therapies - CD4 Reconstitution Trial: T-Cell Proliferation Without HIV Increase
AIDS and Cancer Therapies - Onconase Cytotoxic and Anti-Proliferative Mechanism Action Elucidated
Antisense Technology - Researchers Report In Vitro Results of Gem 91 Resistance Profile
Breast Cancer (A-MYB Gene) - Gene Linked to Breast Cancer and Male Infertility
Cancer Therapies (Immunogene Therapy) - Cancer Treatment Trials Begin at University Hospitals
HIV Gene Therapy - Success Reported Using Therapy To Protect Cells from HIV
Immunology (HCV) - Humoral Immune Selection Critical in HCV HVR1 Variation
Pathenogenesis (TB) - Serine/Threonine Protein Kinase Characterized in M. tb
Pediatrics (Autoimmune Hepatitis) - Outcome Same in ANA/SMA and LKM-1 Positive Children
Vaccine Development - Minigene Vaccine Links B, CTL, and Th Epitopes Vs. Multiple Pathogens
Cancer Gene Therapy - "Induction of Apoptosis in Non-Small Cell Lung Cancer Cells by p16INK4."
Antisense Technology - "Infusions of Tyrosine Hydroxylase Antisense Oligodeoxynucleotide into Substantia Nigra of the Rat: Effects on Tyrosine Hydroxylase mRNA and Protein Content, Striatal Dopamine Release and Behaviour."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.